Uncategorized

Oyster Point Pharma Expands Executive Leadership Team

by Business Wire • 2019/09/19 • 0 Comments

PRINCETON, N.J.--(BUSINESS WIRE)--Oyster Point Pharma announces the appointment of Dan Lochner, MBA as its Chief Financial Officer and John Snisarenko, MBA as Chief Commercial Officer.

Full Story →

← Aerie Pharmaceuticals Submits Prior Approval Supplement to the U.S. Food and Drug Administration to Allow Production of Rocklatan® (netarsudil and latanoprost ophthalmic solution) 0.02%/0.005% in its Athlone Ireland Facility

Machine Learning Helps Predict Risk of Heart Failure in Patients with Diabetes →

Post navigation